Diseases & Conditions – TIPS: Deep Dive Interviews

Expanding the Scope of Service at the Community Pharmacy with Hector Bremner

February 23, 2023 donlee 0 Comments

On this episode, we talk with Hector Bremner. Hector is CEO of Avricore Health which is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward.

Hector helps us see the opportunity for community pharmacies to expand their role, provide a better experience and better outcomes to patients, and to do so in a way that is equitable, good for the pharmacy, good for the pharmacist, and good for the healthcare system as a whole.

Overcoming Emergent Problems in a Deepening Crisis with Dr. Angela Rasmussen

January 18, 2021 donlee 0 Comments

The COVID-19 pandemic continues to worsen by most objective measures. We’re breaking records for cases, deaths, and hospitalizations on a regular basis, and many of our hospitals are operating at or near capacity. Further complicating the situation, scientists are tracking the “UK variant” that is more transmissible, and our vaccine distribution has fallen well short of expectations. Emergent problems in a deepening crisis, of course, make us vulnerable to knee-jerk reactions that distract us from the known path to getting the pandemic under control.

Steffanie Strathdee: Slaying Superbugs and Saving Lives

February 10, 2020 michaeldiamond 1 Comment

You are going to love this story of love, determination, resourcefulness and triumph. Steffanie cured her husbands illness with the help of three universities, the US Navy and researchers from across the world. What she discovered in the process is a super weapon against multidrug antimicrobial resistant diseases, which are expected to kill more than ten million people per year by 2050.

Antibiotic Resistance Survivor, Scientist and Activist: David Ricci – Part 2

December 27, 2019 michaeldiamond 1 Comment

In Part 1, we heard David Ricci’s harrowing tale of volunteering at an HIV clinic in Kolkata, India where he was hit by a train. His life-threating injuries lead to the amputation of his leg at a clinic in the slums. Despite that traumatic experience, he endured even greater trauma when he returned home to Seattle and spent over a year combatting an antibiotic-resistant infection. This podcast is a great primer on the challenges and potential solutions to the dangers of antimicrobial resistance and some of the reasons that it has not received the attention it deserves. Listen to Part 2 of David’s story and be inspired by this survivor, scientist and activist.

Antibiotic Resistance Survivor, Scientist and Activist: David Ricci – Part 1

December 19, 2019 michaeldiamond 0 Comments

In 2011, David was working at an HIV orphanage in Kolkata, India when he was hit by a train. He suffered profound injuries to his leg and was rushed to a clinic in the slums by rickshaw where his leg was amputated just below the knee. When he returned home to Seattle about a month later, he learned that he had been infected by several antibiotic-resistant bacteria. His doctors did not have clear treatment path for him, as they had never seen as case like David’s. He did not think he would survive this trauma.

Understanding Infectious Agents in the Environment | Dr. Syed Sattar and Bahram Zargar

November 6, 2019 donlee 0 Comments

What happens to an infectious agent once it leaves the human body? Well, it ends up in our cars, airplanes, food, water and soil. If we know how that contagion behaves “in the wild”, then we’ll be able to kill it, filter it, or otherwise prevent it from proliferating, and potentially improve the lives of millions of people in the process. This is the study of Environmental Microbiology and it’s a topic that today’s guest has spent more than 30 years trying to understand.

Redefining Sepsis | Michael Ackerman

September 19, 2019 donlee 0 Comments

Sepsis definitions and protocols have been around for some time, but have been undergoing major changes. Additionally, sepsis is under scrutiny from CMS at the federal level and is subject to public reporting in many states. All of this, plus the importance of quickly diagnosing and treating the condition puts clinicians in a difficult spot. Many times they’ll find themselves treating to the protocol, even when their clinical instincts suggest something else.

Shining a Light on C. diff – Christian John Lillis

September 14, 2019 donlee 0 Comments

Clostridium difficile (klos-TRID-e-um dif-uh-SEEL), often called C. difficile or C. diff impacts 453,000 people every year. And with 29,000 associated deaths, it takes more lives than AIDS and drunk-driving combined. Yet, most people have never even heard of it. That’s a big problem because you can’t protect yourself from a threat when you don’t even know it exists.